Macrogenics Inc (NAS:MGNX)
$ 4.36 0.25 (6.07%) Market Cap: 273.08 Mil Enterprise Value: 107.83 Mil PE Ratio: 0 PB Ratio: 2.57 GF Score: 60/100

MacroGenics Inc ASCO 2020 Conference Call Transcript

May 29, 2020 / 08:30PM GMT
Release Date Price: $19.24 (-16.35%)
Operator

Good afternoon. We will begin the MacroGenics 2020 ASCO Conference Call in just a moment. (Operator Instructions)

At this point, I will turn the call over to Anna Krassowska, Vice President, Investor Relations and Corporate Communications of MacroGenics.

Anna Krassowska
MacroGenics, Inc. - VP of IR & Corporate Communications

Thank you, Victor. Good afternoon. And welcome to the MacroGenics conference call to review the preliminary clinical results from the ongoing Phase I studies of MGD013 and MGC018 that are part of the American Society of Clinical Oncology, ASCO20 Virtual Scientific Program. The presentation that accompanies this conference call is available under the Investors tab on the website of macrogenics.com. You can also listen to this conference call live via webcast on our website where it will be archived for 30 days beginning approximately 2 hours after the call is completed. For those of you listening by webcast, note that the slides for the accompanying presentation are advanced by the viewer.

Before we begin, I would

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot